CHECK OUT OUR NOVEMBER ISSUE
 
Urology Times cover
View the latest issue online.
Combination therapy addressed in amended OAB guideline
In this interview, Sandip Vasavada, MD, discusses the rationale behind the recent amendment to the AUA/SUFU guideline for overactive bladder, the role of OAB drugs in the treatment of nocturia, and treatment of refractory OAB.
Read the interview
 
As 2020 approaches, it’s time to review your financial strategies
"This time of year presents the perfect opportunity to review and possibly adjust your financial planning strategies," writes Jeff Witz, CFP.
Get his advice
 
SURVEY
 
Is DRE still a relevant tool in the management of prostate cancer?
 
MORE FROM UROLOGY TIMES
 
Urology groups: 340B program reform needed
Why private equity is right for some, not all, practices